Skip to main content
Erschienen in: World Journal of Urology 11/2017

17.05.2017 | Original Article

Venous thromboembolism after nephrectomy: incidence, timing and associated risk factors from a national multi-institutional database

verfasst von: Brian J. Jordan, Richard S. Matulewicz, Brian Trihn, Shilajit Kundu

Erschienen in: World Journal of Urology | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the rate of venous thromboembolism (VTE) after nephrectomy with specific focus on event timing and location (before or after hospital discharge) in order to identify modifiable risk factors and establish benchmarks for preventive interventions.

Methods

Using the ACS-NSQIP database, we identified patients undergoing nephrectomy from 2006 to 2012. Patients were analyzed in two cohorts: collectively and by surgical approach [open vs. lap/robotic (MIS)]. Rates of deep vein thrombosis (DVT) and pulmonary embolus (PE) were assessed and time to each event was established in relation to discharge status. Logistic regression analysis was performed to assess association between preoperative risk factors, surgical variables, and VTE.

Results

In total, 13,208 patients met inclusion criteria. The overall rate of VTE was 1.2% (PE = 0.5% and DVT = 0.8, 0.1% DVT and PE). Using regression analysis, diabetes, dependent functional status, and longer operative time were associated with higher odds of DVT. For PE, dyspnea, disseminated cancer, and longer operative time were significant associations. The rate of VTE was higher in open surgery compared to MIS (2 vs. 0.8%, p < 0.001). Median times to DVT and PE were 8.5 and 6 days, respectively, with 53.3% of DVTs and 63.1% of PEs occurring prior to discharge.

Conclusions

The overall rate of VTE after nephrectomy is low, occurs roughly one week after surgery, and is associated with longer hospital stays. Certain patient factors, open surgical approach, and longer operative times were associated with higher odds of post-operative VTE; these patients may benefit from more aggressive prophylaxis.
Literatur
1.
Zurück zum Zitat Kakkar AK et al (2005) Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy. Thromb Haemost 94(4):867–871PubMed Kakkar AK et al (2005) Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy. Thromb Haemost 94(4):867–871PubMed
2.
Zurück zum Zitat Heit JA et al (1999) Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 159(5):445–453CrossRefPubMed Heit JA et al (1999) Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 159(5):445–453CrossRefPubMed
3.
Zurück zum Zitat Horlander KT, Mannino DM, Leeper KV (2003) Pulmonary embolism mortality in the United States, 1979–1998. Arch Intern Med 163:1711–1717CrossRefPubMed Horlander KT, Mannino DM, Leeper KV (2003) Pulmonary embolism mortality in the United States, 1979–1998. Arch Intern Med 163:1711–1717CrossRefPubMed
4.
Zurück zum Zitat Tyson MD et al (2014) Venous thromboembolism after urological surgery. J Urol 192(3):793–797CrossRefPubMed Tyson MD et al (2014) Venous thromboembolism after urological surgery. J Urol 192(3):793–797CrossRefPubMed
5.
Zurück zum Zitat Sun AJ et al (2015) Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events. J Urol 193(2):565–569CrossRefPubMed Sun AJ et al (2015) Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events. J Urol 193(2):565–569CrossRefPubMed
6.
Zurück zum Zitat Tyritzis SI et al (2015) Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection. J Urol 193(1):117–125CrossRefPubMed Tyritzis SI et al (2015) Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection. J Urol 193(1):117–125CrossRefPubMed
8.
Zurück zum Zitat Sallah S, Wan JY, Nguyen NP (2002) Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 87(4):575–579PubMed Sallah S, Wan JY, Nguyen NP (2002) Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 87(4):575–579PubMed
9.
Zurück zum Zitat Pettus JA et al (2006) Perioperative clinical thromboembolic events after radical or partial nephrectomy. Urology 68(5):988–992CrossRefPubMed Pettus JA et al (2006) Perioperative clinical thromboembolic events after radical or partial nephrectomy. Urology 68(5):988–992CrossRefPubMed
10.
Zurück zum Zitat Dyer J, Wyke S, Lynch C (2013) Hospital episode statistics data analysis of postoperative venous thromboembolus in patients undergoing urological surgery: a review of 126,891 cases. Ann R Coll Surg Engl 95(1):65–69CrossRefPubMedPubMedCentral Dyer J, Wyke S, Lynch C (2013) Hospital episode statistics data analysis of postoperative venous thromboembolus in patients undergoing urological surgery: a review of 126,891 cases. Ann R Coll Surg Engl 95(1):65–69CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Rice KR, Brassell SA, McLeod DG (2010) Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol 12(2–3):e111–e124PubMedPubMedCentral Rice KR, Brassell SA, McLeod DG (2010) Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol 12(2–3):e111–e124PubMedPubMedCentral
12.
Zurück zum Zitat Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293(6):715–722CrossRefPubMed Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293(6):715–722CrossRefPubMed
13.
Zurück zum Zitat Abel EJ et al (2014) Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. JSLS 18(2):282–287CrossRefPubMedPubMedCentral Abel EJ et al (2014) Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. JSLS 18(2):282–287CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Becker A et al (2014) Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption. Urology 83(6):1285–1291CrossRefPubMed Becker A et al (2014) Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption. Urology 83(6):1285–1291CrossRefPubMed
15.
Zurück zum Zitat Becker A et al (2015) Laparoscopic versus open partial nephrectomy for clinical T1 renal masses: no impact of surgical approach on perioperative complications and long-term postoperative quality of life. World J Urol 33(3):421–426CrossRefPubMed Becker A et al (2015) Laparoscopic versus open partial nephrectomy for clinical T1 renal masses: no impact of surgical approach on perioperative complications and long-term postoperative quality of life. World J Urol 33(3):421–426CrossRefPubMed
17.
Zurück zum Zitat Rasmussen MS (2002) Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev 28(3):141–144CrossRefPubMed Rasmussen MS (2002) Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev 28(3):141–144CrossRefPubMed
18.
Zurück zum Zitat Rasmussen MS et al (2006) Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost 4(11):2384–2390CrossRefPubMed Rasmussen MS et al (2006) Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost 4(11):2384–2390CrossRefPubMed
19.
Zurück zum Zitat Selby LV et al (2016) Preoperative chemoprophylaxis is safe in major oncology operations and effective at preventing venous thromboembolism. J Am Coll Surg 222(2):129–137CrossRefPubMed Selby LV et al (2016) Preoperative chemoprophylaxis is safe in major oncology operations and effective at preventing venous thromboembolism. J Am Coll Surg 222(2):129–137CrossRefPubMed
20.
Zurück zum Zitat Schmid M et al (2016) Causes of hospital readmissions after urologic cancer surgery. Urol Oncol 34(5):236 e1–236 e11CrossRef Schmid M et al (2016) Causes of hospital readmissions after urologic cancer surgery. Urol Oncol 34(5):236 e1–236 e11CrossRef
Metadaten
Titel
Venous thromboembolism after nephrectomy: incidence, timing and associated risk factors from a national multi-institutional database
verfasst von
Brian J. Jordan
Richard S. Matulewicz
Brian Trihn
Shilajit Kundu
Publikationsdatum
17.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 11/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-017-2046-0

Weitere Artikel der Ausgabe 11/2017

World Journal of Urology 11/2017 Zur Ausgabe

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.